CLOS
ATRA icon

Compagnie Lombard Odier SCmA’s Atara Biotherapeutics ATRA Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-180
Closed -$186K – 553
2018
Q3 		$186K Hold
180
– – 0.01% 299
2018
Q2 		$165K Hold
180
– – 0.01% 304
2018
Q1 		$175K Sell
180
-180
-50% -$164K 0.01% 318
2017
Q4 		$162K Buy
360
+180
+100% +$66.5K ﹤0.01% 426
2017
Q3 		$74K Hold
180
– – ﹤0.01% 486
2017
Q2 		$63K Hold
180
– – ﹤0.01% 491
2017
Q1 		$92K Buy
180
+80
+80% +$33.1K ﹤0.01% 459
2016
Q4 		$35K Hold
100
– – ﹤0.01% 647
2016
Q3 		$53K Hold
100
– – ﹤0.01% 673
2016
Q2 		$56K Buy
100
+60
+150% +$28.8K ﹤0.01% 649
2016
Q1 		$19K Hold
40
– – ﹤0.01% 834
2015
Q4 		$26K Buy
+40
New +$30.3K ﹤0.01% 770

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return